MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a
Y Zhang, T Chao, R Li, W Liu, Y Chen, X Yan… - Journal of molecular …, 2009 - Springer
MicroRNAs are ∼21nt single-stranded RNAs and function as regulators of gene expression.
Previous studies have shown that microRNAs play crucial roles in tumorigenesis by …
Previous studies have shown that microRNAs play crucial roles in tumorigenesis by …
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
Y Chen, W Liu, T Chao, Y Zhang, X Yan, Y Gong… - Cancer letters, 2008 - Elsevier
MicroRNAs have been linked to different cancer-related processes. The microRNA miR-21
appears to function as an anti-apoptosis factor in glioblastomas. However, the functional …
appears to function as an anti-apoptosis factor in glioblastomas. However, the functional …
The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells
X Tan, S Wang, B Yang, L Zhu, B Yin, T Chao, J Zhao… - PloS one, 2012 - journals.plos.org
Migration-proliferation dichotomy is a common mechanism in gliomagenesis; however, an
understanding of the exact molecular mechanism of this “go or grow” phenomenon remains …
understanding of the exact molecular mechanism of this “go or grow” phenomenon remains …
miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade
J Zhang, B Su, C Gong, Q Xi, T Chao - Biochemical and biophysical …, 2016 - Elsevier
miR-214 is involved in numerous physiological and pathological processes including
tumorigenesis. However, the function of miR-214 in the development and treatment of breast …
tumorigenesis. However, the function of miR-214 in the development and treatment of breast …
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
J Liu, T Chao, Y Liu, C Gong, Y Zhang, H Xiong - Pharmaceutics, 2023 - mdpi.com
Cancer is a top global public health concern. At present, molecular targeted therapy has
emerged as one of the main therapies for cancer, with high efficacy and safety. The medical …
emerged as one of the main therapies for cancer, with high efficacy and safety. The medical …
Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
…, L Yang, J Zhou, Y Xue, Y Li, Z Chang, J Li, T Chao… - Cell Metabolism, 2024 - cell.com
Immunomodulatory effects of long-chain fatty acids (LCFAs) and their activating enzyme,
acyl-coenzyme A (CoA) synthetase long-chain family (ACSL), in the tumor microenvironment …
acyl-coenzyme A (CoA) synthetase long-chain family (ACSL), in the tumor microenvironment …
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53
The tumour suppressor p53 transactivates the expression of its target genes to exert its
functions. Here, we identify a pleckstrin homology domain-containing protein (PHLDB3)-…
functions. Here, we identify a pleckstrin homology domain-containing protein (PHLDB3)-…
[HTML][HTML] Improving the prediction of human microRNA target genes by using ensemble algorithm
X Yan, T Chao, K Tu, Y Zhang, L Xie, Y Gong, J Yuan… - FEBS letters, 2007 - Elsevier
MicroRNAs are a class of small endogenous noncoding RNAs which play important regulatory
roles mainly by post-transcriptional depression. Finding miRNA target genes will help a …
roles mainly by post-transcriptional depression. Finding miRNA target genes will help a …
[HTML][HTML] Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation
…, L Zhuang, N Han, Q Chu, T Chao… - International …, 2013 - spandidos-publications.com
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are being widely
used as targeted therapy in non-small cell lung cancer (NSCLC), but most cases acquire drug-…
used as targeted therapy in non-small cell lung cancer (NSCLC), but most cases acquire drug-…
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab
T Zhou, Q Shen, H Peng, T Chao, L Zhang… - Annals of …, 2018 - Springer
Pneumonitis is a rare but severe and potentially fatal adverse effect in chemotherapy of
lymphoma. This study is aimed to investigate the incidence of interstitial pneumonitis in non-…
lymphoma. This study is aimed to investigate the incidence of interstitial pneumonitis in non-…